Healthcare Industry News:  Palomar Medical Technologies 

Devices Personnel

 News Release - November 20, 2007

Candela Appoints Chief Operating Officer

WAYLAND, Mass.--(HSMN NewsFeed)--Candela Corporation (NASDAQ:CLZR ) announced today that it has appointed Jay D. Caplan in the newly created position of Chief Operating Officer.


Most recently, Mr. Caplan was Chief Technology Officer at InfraReDx, a venture funded start-up. At InfraReDx, Mr. Caplan directed the development of a novel coronary diagnostic product from concept to clinical validation. Prior to InfraReDx, Mr. Caplan was Vice President of Operations at Thermo Cardiosystems, a supplier of ventricular devices for heart failure. Mr. Caplan was previously employed at Candela between 1988 and 2000. During that time, he held positions in Marketing, Finance, International and, later, was Vice President of Operations.

Mr. Caplan holds a B.S. in Electrical Engineering from the Massachusetts Institute of Technology, and an M.B.A. with distinction from the Wharton School of The University of Pennsylvania. He is an inventor on both issued and pending patents, and is the author of several peer-reviewed publications and medical journals.

Gerard E. Puorro, Candela’s President and Chief Executive Officer, said: “Jay returns to Candela with an impressive résumé of experience across all functions, which will be of great assistance to us as we return to a growth path and as the leader in our industry.”

About CANDELA: Candela Corporation manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 70 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 18 years ago, and currently has an installed base of an estimated 12,000 lasers worldwide. Visit Candela on the Web at http://www.candelalaser.com.

Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Such statements may relate to, among other things, our future revenue, gross margin, expense levels and earnings, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock. The risks and uncertainties that may affect forward-looking statements include, among others: the cancellation or deferral of customer orders, the risk of an adverse judgment in the patent litigation with Palomar Medical Technologies, Inc., dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, unanticipated increases in expenses, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.


Source: Candela

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.